GlobeNewswire Inc.··Argenxargenx to Report Q1 2026 Results; Immunology Firm Signals Strategic Update
argenx will report Q1 2026 financial results on May 7, 2026, offering investors insight into the immunology company's clinical progress and commercial trajectory.
ARGXautoimmune diseasesconference call